Literature DB >> 25367230

[Check-ups and screening for young people: what is reasonable with respect to psychiatric disorders?].

A Pfennig1, J Klosterkötter.   

Abstract

BACKGROUND: Severe mental illnesses become manifested early in life. First episodes are suffered in young adulthood at the latest and early symptoms and signs are often already reported in childhood and adolescence. Therefore, it is exactly these adolescents and young adults who have to be reached to detect signs early.
OBJECTIVES: In this article the check-ups and screening procedures routinely offered for this target group as well as the role of groups of persons who accompany young people in a variety of contexts are illustrated. Potential extensions with elements and structures for the early recognition of severe mental illnesses are outlined.
RESULTS: With the integration of psychiatric peculiarities and drug consumption into the diagnostic battery of the first adolescence healthcare examination (Jugendgesundheitsuntersuchung J1), the often already established familiarity of young persons and the waiving of costs by the health insurances, the J1 seems to be well-suited to provide a rough screening for precursor stages and risk factors for the development of severe mental illnesses and for the detection of a suspected manifest mental disorder. The primary role of most persons working with young people is to be a contact partner and to help transferring the person to the adequate service. Several early recognition centers were founded in Germany to offer low-threshold contact services in the view of existing barriers to care for help-seeking young persons and to provide the complex diagnostics.
CONCLUSIONS: The adolescence healthcare examinations can be a useful element for early detection of mental disorders and damaging behavior if the utilization rate is high and actions taken in case of suspected beginning disorder/damaging behavior are evaluated. To date, screening instruments for psychiatric disorders should not be used in wide population classes without group-specific targets and without direct contact between therapists and patients. Already established preventive services and initiatives should be interlinked. The health effects of the actions have to be analyzed.

Entities:  

Mesh:

Year:  2014        PMID: 25367230     DOI: 10.1007/s00115-013-3979-1

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  9 in total

1.  [Services for the early recognition of psychoses and bipolar disorders in Germany: inventory survey study].

Authors:  K Leopold; A Nikolaides; M Bauer; A Bechdolf; C U Correll; F Jessen; G Juckel; A Karow; M Lambert; J Klosterkötter; S Ruhrmann; S Pfeiffer; A Pfennig
Journal:  Nervenarzt       Date:  2015-03       Impact factor: 1.214

2.  The impact of substance use disorders on clinical outcome in 643 patients with first-episode psychosis.

Authors:  M Lambert; P Conus; D I Lubman; D Wade; H Yuen; S Moritz; D Naber; P D McGorry; B G Schimmelmann
Journal:  Acta Psychiatr Scand       Date:  2005-08       Impact factor: 6.392

3.  Development and validation of a screening instrument for bipolar spectrum disorder: the Mood Disorder Questionnaire.

Authors:  R M Hirschfeld; J B Williams; R L Spitzer; J R Calabrese; L Flynn; P E Keck; L Lewis; S L McElroy; R M Post; D J Rapport; J M Russell; G S Sachs; J Zajecka
Journal:  Am J Psychiatry       Date:  2000-11       Impact factor: 18.112

4.  Demographic and clinical characteristics of individuals in a bipolar disorder case registry.

Authors:  David J Kupfer; Ellen Frank; Victoria J Grochocinski; Patricia A Cluss; Patricia R Houck; Debra A Stapf
Journal:  J Clin Psychiatry       Date:  2002-02       Impact factor: 4.384

5.  Long-term implications of early onset in bipolar disorder: data from the first 1000 participants in the systematic treatment enhancement program for bipolar disorder (STEP-BD).

Authors:  Roy H Perlis; Sachiko Miyahara; Lauren B Marangell; Stephen R Wisniewski; Michael Ostacher; Melissa P DelBello; Charles L Bowden; Gary S Sachs; Andrew A Nierenberg
Journal:  Biol Psychiatry       Date:  2004-05-01       Impact factor: 13.382

6.  Mood episodes and mood disorders: patterns of incidence and conversion in the first three decades of life.

Authors:  Katja Beesdo; Michael Höfler; Ellen Leibenluft; Roselind Lieb; Michael Bauer; Andrea Pfennig
Journal:  Bipolar Disord       Date:  2009-09       Impact factor: 6.744

7.  The National Depressive and Manic-depressive Association (DMDA) survey of bipolar members.

Authors:  J D Lish; S Dime-Meenan; P C Whybrow; R A Price; R M Hirschfeld
Journal:  J Affect Disord       Date:  1994-08       Impact factor: 4.839

8.  Efficacy of a systematic depression management program in high utilizers of primary care: a randomized trial.

Authors:  Anne Berghöfer; Astrid Hartwich; Michael Bauer; Jürgen Unützer; Stefan N Willich; Andrea Pfennig
Journal:  BMC Health Serv Res       Date:  2012-09-03       Impact factor: 2.655

9.  Toward a global view of alcohol, tobacco, cannabis, and cocaine use: findings from the WHO World Mental Health Surveys.

Authors:  Louisa Degenhardt; Wai-Tat Chiu; Nancy Sampson; Ronald C Kessler; James C Anthony; Matthias Angermeyer; Ronny Bruffaerts; Giovanni de Girolamo; Oye Gureje; Yueqin Huang; Aimee Karam; Stanislav Kostyuchenko; Jean Pierre Lepine; Maria Elena Medina Mora; Yehuda Neumark; J Hans Ormel; Alejandra Pinto-Meza; José Posada-Villa; Dan J Stein; Tadashi Takeshima; J Elisabeth Wells
Journal:  PLoS Med       Date:  2008-07-01       Impact factor: 11.069

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.